Novartis wins FDA approval for two blood pressure drugs
Novartis obtained FDA clearance for Diovan HCT and Exforge, two single-pill treatments for high blood pressure. The approval allows the use of the combination drugs as an initial treatment for hypertension patients who may need multiple regimens, the company said.
Bloomberg | 08/04
This story published in AANP SmartBrief on 08/04/2008
More from SmartBrief:
Nightly aspirin reduces BP in prehypertension patients
Friday, August 14, 2009
Resistant hypertension linked to excess salt intake
Tuesday, July 21, 2009
Researchers trace memory problems to high blood pressure
Wednesday, August 26, 2009
Get stories like these delivered daily for FREE:
|
AANP SmartBrief
Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more |
|